Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-9-6
pubmed:abstractText
We investigated the effect of 5-HT receptor antagonists on mechanical hyperalgesia observed in a neuropathic pain rat model prepared by chronic constriction injury of the sciatic nerve. NAN-190, a 5-HT 1A receptor antagonist, (-)-pindolol, a 5-HT 1A/1B receptor antagonist, and tropisetron, a 5-HT(3/4) receptor antagonist, did not affect the pain threshold in the hyperalgesic hind limb to the same extent as in the normal hind limb. However, sarpogrelate and ketanserin, 5-HT 2A receptor antagonists, significantly elevated the pain threshold in the hyperalgesic hind limb, but not in the normal hind limb. In spite of its high affinity for the 5-HT 2A receptor, methysergide only slightly elevated the pain threshold in the hyperalgesic hind limb. Pre-treatment with methysergide significantly antagonized the inhibitory effect of sarpogrelate on hyperalgesia. Furthermore, the 5-HT 2A receptor specific binding activity of 3H-ketanserin determined for the hyperalgesic hind limb did not differ from that of the normal hind limb. From these results, we propose that the 5-HT 2A receptor in the hyperalgesic hind paw function as an agonist-independent active receptor following constriction of the sciatic nerve, and that sarpogrelate and ketanserin act as inverse agonists of this receptor and suppress its activation. Methysergide may act as a neutral antagonist that blocks the effect of inverse agonists on the 5-HT 2A receptor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0197-0186
pubmed:author
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
394-400
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16051396-Animals, pubmed-meshheading:16051396-Binding, Competitive, pubmed-meshheading:16051396-Binding Sites, pubmed-meshheading:16051396-Denervation, pubmed-meshheading:16051396-Disease Models, Animal, pubmed-meshheading:16051396-Drug Interactions, pubmed-meshheading:16051396-Hyperalgesia, pubmed-meshheading:16051396-Ketanserin, pubmed-meshheading:16051396-Ligation, pubmed-meshheading:16051396-Male, pubmed-meshheading:16051396-Neuralgia, pubmed-meshheading:16051396-Pain Threshold, pubmed-meshheading:16051396-Peripheral Nerves, pubmed-meshheading:16051396-Peripheral Nervous System Diseases, pubmed-meshheading:16051396-Radioligand Assay, pubmed-meshheading:16051396-Rats, pubmed-meshheading:16051396-Rats, Sprague-Dawley, pubmed-meshheading:16051396-Receptor, Serotonin, 5-HT2A, pubmed-meshheading:16051396-Sciatic Neuropathy, pubmed-meshheading:16051396-Sensory Receptor Cells, pubmed-meshheading:16051396-Serotonin 5-HT2 Receptor Antagonists, pubmed-meshheading:16051396-Serotonin Antagonists, pubmed-meshheading:16051396-Serotonin Receptor Agonists, pubmed-meshheading:16051396-Succinates
pubmed:year
2005
pubmed:articleTitle
Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain.
pubmed:affiliation
Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima 729-0292, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't